US Patent 11413346 Rotavirus vaccines
Patent 11413346 was granted and assigned to CureVac on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114133460
Date of Patent
August 16, 2022
0Patent Application Number
157744160
Date Filed
November 9, 2016
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114133460
Date of Patent
August 16, 2022
0Patent Application Number
157744160
Date Filed
November 9, 2016
0Patent Primary Examiner
Edits on 17 Aug, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+457 characters)
US Patent 11413346 Rotavirus vaccines
Article
The present invention provides mRNA sequences comprising at least one coding region, encoding for at least one epitope of a protein, or of a fragment, variant or derivative thereof, of a virus of the genus rotavirus. Particularly preferred is the protein respectively the protein cleavage product VP8* of rotavirus. The mRNA sequence may be used as a vaccine or generally as a pharmaceutical composition for prophylaxis or treatment of rotavirus infections.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11413346
Date of Patent
August 16, 2022
Patent Application Number
15774416
Date Filed
November 9, 2016
Patent Primary Examiner
Find more entities like US Patent 11413346 Rotavirus vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
